According to Nevro 's latest financial reports the company's total liabilities are $0.34 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.34 B | 22.99% |
2022-12-31 | $0.27 B | 2.81% |
2021-12-31 | $0.27 B | -32.43% |
2020-12-31 | $0.40 B | 58.3% |
2019-12-31 | $0.25 B | 16.39% |
2018-12-31 | $0.21 B | 6.22% |
2017-12-31 | $0.20 B | 12.85% |
2016-12-31 | $0.18 B | 220.81% |
2015-12-31 | $56.59 M | 86% |
2014-12-31 | $30.42 M | 281.95% |
2013-12-31 | $7.96 M | 44.92% |
2012-12-31 | $5.49 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $51.88 B | 15,045.61% | ๐บ๐ธ USA |
Abiomed ABMD | $0.15 B | -54.24% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | $2.04 B | 496.73% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $0.32 B | -4.67% | ๐บ๐ธ USA |